Division of Medical Genetics, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Serimmune, Inc, Goleta, California, USA.
Birth Defects Res. 2024 Sep;116(9):e2400. doi: 10.1002/bdr2.2400.
Gastroschisis is a birth defect with the greatest risk among women <20 years of age.
Pregnant women attending the University of Utah's Maternal-Fetal Medicine Diagnostic Center between 2011 and 2017 for either their routine diagnostic ultrasound or referral were recruited (cases: pregnant women with fetal gastroschisis, n = 53 participated/57, 93%; controls: pregnant women without fetal abnormalities, n = 102 participated/120, 85%). A clinic coordinator consented and interviewed women and obtained a blood sample and prenatal medical records. We evaluated self-reported maternal characteristics, risk factors, and infections. To assess pathogen seropositivity we used Serimmune's Serum Epitope Repertoire Analysis validated 35 pathogen panels and Chlamydia trachomatis and compared seropositivity to self-report and prenatal medical record screening to assess sensitivity.
Cases were more likely to report a younger age at sexual debut (p = <0.01), more sexual partners (p = 0.02), being unmarried (p < 0.01), changing partners between pregnancies (p = <0.01), smoking cigarettes (<0.01), and a recent sexually transmitted infection (STI) (p = 0.02). No differences were observed for self-report of illicit drug use or periconceptional urinary tract infections. Cases had a higher seropositivity for cytomegalovirus (p = 0.01). No differences were observed for herpes simplex I, II, or Epstein-Barr. Though based on small numbers, C. trachomatis seropositivity was highest in cases (17%) compared to controls (8.8%) with the highest proportion observed in case women <20 years of age (cases 33%; controls 0%). Any STI (self-report or seropositivity) was also highest among cases <20 years of age (cases 47%; controls 0%). Among C. trachomatis seropositive women, self-report and prenatal medical record sensitivity was 27.8% and 3%, respectively.
Cases were more likely to engage in behaviors that can increase their risk of exposure to sexually transmitted pathogens. Case women <20 years of age had the highest proportion of C. trachomatis seropositivity and any STI. Prenatal medical records and self-report were inadequate to identify a recent chlamydial infection whereas, the SERA assay is a novel approach for evaluating subclinical infections that may impact the developing embryo.
先天性腹裂是一种出生缺陷,在 20 岁以下的女性中风险最高。
2011 年至 2017 年间,在犹他大学母婴医学诊断中心接受常规诊断性超声检查或转介的孕妇入组(病例:胎儿先天性腹裂孕妇,n=53/57,93%;对照组:无胎儿异常孕妇,n=102/120,85%)。一名临床协调员征得同意并对孕妇进行访谈,并采集血样和产前病历。我们评估了自报的产妇特征、危险因素和感染情况。为了评估病原体血清阳性率,我们使用 Serimmune 的血清表位谱分析验证了 35 种病原体面板和沙眼衣原体,并将血清阳性率与自报和产前病历筛查进行比较,以评估敏感性。
病例组更有可能报告初次性行为年龄较小(p<0.01)、性伴侣较多(p=0.02)、未婚(p<0.01)、妊娠间更换性伴侣(p<0.01)、吸烟(p<0.01)和近期性传播感染(p=0.02)。自报使用非法药物或围孕期尿路感染的差异无统计学意义。病例组巨细胞病毒血清阳性率较高(p=0.01)。单纯疱疹 I、II 或 Epstein-Barr 无差异。虽然基于小样本量,但衣原体血清阳性率在病例组中最高(17%),对照组中为 8.8%,在<20 岁的病例组中观察到的比例最高(病例组 33%;对照组 0%)。<20 岁的病例组中任何性传播感染(自报或血清阳性)的比例也最高(病例组 47%;对照组 0%)。在衣原体血清阳性的女性中,自报和产前病历的敏感性分别为 27.8%和 3%。
病例组更有可能接触性传播病原体,从而增加感染风险。<20 岁的病例组中衣原体血清阳性率和任何性传播感染的比例最高。产前病历和自报不足以发现近期的衣原体感染,而 SERA 检测是评估可能影响发育中胚胎的亚临床感染的新方法。